Delivery Order SPE2DB20D3304-SPE2DB24FW7N9

Award Date 9/29/24
Potential Completion Date 9/30/24
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,037.84 contract is for the delivery of SPIKEVAX COVID-19 vaccine vials to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. federal government. The contract, valued at $3,552.79, is for the provision of SPIKEVAX (COVID-19 vaccine) syringes (0.5ML) to DLA facilities supporting the Department of Defense. The contract has an ultimate completion date of June 20, 2024 and is a Firm Fixed Price arrangement. This Delivery Order is issued under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,672.00, is for the procurement of SPIKEVAX COVID-19 vaccine syringes (0.5ML) for individuals 12 years and older. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides the delivery of 4,564,339,104 units of the Spikevax COVID-19 vaccine (0.5 mL syringes) for individuals aged 12 and up, with a ceiling value of $7,771.50 and a performance period through April 29, 2024. This delivery order is part of a larger indefinite delivery...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SPIKEVAX COVID-19 vaccine vials (0.5mL) for individuals aged 12 and up. The contract has a potential value of $44,800.00 and a completion date of February 6, 2024. This delivery order is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a...
This is a $5,011.23 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML vaccines, with an ultimate completion date of April 1, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of SPIKEVAX COVID-19 vaccine doses (0.5 ml vials) in support of the 12 years and up population. The $1,441.19 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through August 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a $4,881.99 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for the 12 years and up age group. The contract has an ultimate completion date of December 11, 2024 and was awarded on November 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,771.50, is for the delivery of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) to support the 2023-2024 vaccination program for individuals aged 12 and up. The contract has an ultimate completion date of January 29, 2024 and uses a Firm Fixed Price pricing type. There is no set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,993.76 for the supply of SPIKEVAX COVID-19 vaccine doses (0.5 mL vials) in support of the 12 years and older population. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 20, 2024. The contract is structured as a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW7N9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,149,178 units of the SPIKEVAX COVID-19 vaccine for individuals aged 12 and older. The $6,673.40 firm fixed-price contract has a completion date of September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. The contract does not have a set-aside designation.

Generated 12/29/24, 9:01 AM